Both oligomerization and accumulation of alpha-synuclein (ASN) are the key molecular processes involved in the pathophysiology of neurodegenerative diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD), and other synucleinopathies [1]. Here, SNCA is linked to Parkinson disease.